Method of determining the metastatic potential of a tumor

The present invention relates to the field of tumor biology. In particular, it provides a method for determining the risk of metastasis of a tumor, and thus, of cancer-related death, wherein the expression of RAI2, and otionally of other genes, in a tumor sample obtained from the patient is determin...

Full description

Saved in:
Bibliographic Details
Main Authors WERNER, STEFAN, PANTEL, KLAUS, DR, WIKMAN, HARRIET
Format Patent
LanguageEnglish
French
German
Published 26.10.2011
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of tumor biology. In particular, it provides a method for determining the risk of metastasis of a tumor, and thus, of cancer-related death, wherein the expression of RAI2, and otionally of other genes, in a tumor sample obtained from the patient is determined. The invention further provides a kit for determining the expression of RAI2 and/or other genes. A pharmaceutical composition comprising RAI2 in gene or protein form is disclosed, in particular for preventing and/or treating metastasis of a tumor.
Bibliography:Application Number: EP20100004180